These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


185 related items for PubMed ID: 3090400

  • 1. Inappropriate major histocompatibility complex class II expression by thyroid follicular cells in thyroid autoimmune disease and by pancreatic beta cells in type I diabetes.
    Pujol-Borrell R, Todd I, Londei M, Foulis A, Feldmann M, Bottazzo GF.
    Mol Biol Med; 1986 Apr; 3(2):159-65. PubMed ID: 3090400
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Autoimmune thyroid disease--a perspective.
    Volpé R.
    Mol Biol Med; 1986 Feb; 3(1):25-51. PubMed ID: 2870410
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The interaction of MHC and Gm in liability to autoimmune thyroid disease.
    Nagataki S.
    Mol Biol Med; 1986 Feb; 3(1):73-84. PubMed ID: 3007922
    [Abstract] [Full Text] [Related]

  • 7. Autoimmune endocrine diseases.
    De Baets MH.
    Year Immunol; 1989 Feb; 4():264-75. PubMed ID: 2564710
    [No Abstract] [Full Text] [Related]

  • 8. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L, Feve B, Ouary M, Pogu S, Charbonnel B, Saï P.
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [Abstract] [Full Text] [Related]

  • 9. Intrathyroidal MHC class II antigen expression and thyroid autoimmunity.
    Davies TF, Piccinini LA.
    Endocrinol Metab Clin North Am; 1987 Jun; 16(2):247-68. PubMed ID: 3319584
    [Abstract] [Full Text] [Related]

  • 10. T-dependent destruction of thyroid isografts exposed to IFN-gamma.
    Frohman M, Francfort JW, Cowing C.
    J Immunol; 1991 Apr 01; 146(7):2227-34. PubMed ID: 1900881
    [Abstract] [Full Text] [Related]

  • 11. Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect?
    Sospedra M, Obiols G, Babi LF, Tolosa E, Vargas F, Roura-Mir C, Lucas-Martin A, Ercilla G, Pujol-Borrell R.
    J Immunol; 1995 Apr 15; 154(8):4213-22. PubMed ID: 7706756
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies.
    Lucas-Martin A, Foz-Sala M, Todd I, Bottazzo GF, Pujol-Borrell R.
    J Clin Endocrinol Metab; 1988 Feb 15; 66(2):367-75. PubMed ID: 3276724
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Self-thyroid epithelial cell (TEC)-reactive CD8+ T cell lines/clones derived from autoimmune thyroiditis lesions. They recognize self-thyroid antigens directly on TEC to exhibit T helper cell 1-type lymphokine production and cytotoxicity against TEC.
    Sugihara S, Fujiwara H, Niimi H, Shearer GM.
    J Immunol; 1995 Aug 01; 155(3):1619-28. PubMed ID: 7543527
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Molecular pathology of type 1 diabetes.
    Campbell IL, Harrison LC.
    Mol Biol Med; 1990 Aug 01; 7(4):299-309. PubMed ID: 2233244
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.
    Fu Y, Nathan DM, Li F, Li X, Faustman DL.
    J Clin Invest; 1993 May 01; 91(5):2301-7. PubMed ID: 8486790
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.